In-stent Coronary Artery Restenosis Clinical Trial
Official title:
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
This study aims to test the hypothesis that plaque composition differs within a stent between bare metal stents and drug eluting stents (DES). It is possible that a difference in plaque composition seen within a stent may be contributory to the late thrombotic events seen more frequently with DES.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01485068 -
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)
|
N/A | |
Terminated |
NCT03474432 -
SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI
|
N/A | |
Completed |
NCT01296399 -
In-stent Restenosis in Patients With Patent Previous Bare Metal Stent
|
N/A | |
Withdrawn |
NCT03008772 -
REWARDS- In-stent Restenosis
|
||
Withdrawn |
NCT05093244 -
Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment
|
N/A | |
Active, not recruiting |
NCT01623180 -
A Randomized Clinical Evaluation of the BioFreedomâ„¢ Stent
|
N/A | |
Withdrawn |
NCT01411475 -
Prognostic Assessment of Different Pattern of Bifurcation Restenosis
|
||
Completed |
NCT00961181 -
Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis
|
N/A |